Intra-uterine pressure in dysmenorrhea

Intra-uterine pressure recordings in normal and dysmenorrheic women during the menstrual period were analysed regarding amplitude, duration, frequency and peak area of contractions and the resting pressure. The activity of the myometrium showed large between subject variability and no significant difference was found, between the two groups in amplitude and duration of contractions or their frequency. However, there was a consistent difference in peak area at the onset of the menses (p less than 0.01) and there was also a significant decrease in peak area during the menses in the group with dysmenorrhea, with maximum uterine work being performed on the day when the pain was at its worst. The contribution of the pattern of contractility to the etiology of dysmenorrhea is discussed. Abnormal uterine activity as a cause of primary dysmenorrhea was first suggested in the 1930s and 1940s on the basis of intra-uterine pressure recordings (Moir, 1936; Woodbury et al., 1947). Since then, intra-uterine pressure has been measured in a number of studies using a micro-balloon (Lundström et al., 1976; Bygdeman et al., 1979). With the introduction of the highly sensitive micro-transducer catheter it has been possible to make accurate quantitative estimations (Akerlund et al., 1978; Ulmsten & Andersson, 1979) but, to our knowledge, no detailed analysis and quantification of intrauterine pressure recordings in primary dysmenorrhea has been reported. In this paper we publish the results of a study in which daily recordings obtained from women suffering from primary dysmenorrhea were compared with those from a group of women with very similar menstrual patterns but with minimal or no symptoms.

Related Concept Videos

Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
Increased Intracranial Pressure l: Introduction01:14

Increased Intracranial Pressure l: Introduction

Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component expands, CSF and venous blood...
Increased Intracranial Pressure ll: Pathophysiology01:29

Increased Intracranial Pressure ll: Pathophysiology

Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...